Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-27

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Vensun Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for levocetirizine dihydrochloride (Vensun Pharmaceuticals, Inc.) under an ANDA. This action maintains the product’s ava…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)